Roche CEO Confident Business Will Succeed Despite Turmoil
Roche Holding AG’s profit rose 7 percent in the first half, spurred by the Swiss drugmaker’s strategy of combining medicines to better treat cancers of the breast, blood and bowel. Roche’s core earnings, which exclude some items, climbed to 7.74 Swiss francs ($7.86) per share from 7.22 francs a year earlier, the Basel, Switzerland-based company said in a statement Thursday. That exceeded the 7.65-franc estimate of nine analysts surveyed by Bloomberg. Chief Executive Officer Severin Schwan discuss with "On the Move" host Guy Johnson.
Most Recent Videos
JD Wetherspoon's Martin on Earnings, Outlook, Brexit
38:49 - Tim Martin, chairman and founder of JD Wetherspoon, discusses earnings, his outlook for the company, consumer sentiment, the demand for his products and his thoughts on Brexit negotiations. He speaks on "Bloomberg Daybreak: Europe." (Source: Bloomberg)